U.S. Construction Stock News

Burlington Stores (NYSE:BURL) plans to open 110 net new stores in 2026, ahead of earlier expectations. The company is also expanding its corporate office footprint in New York to support a larger organization. These moves reflect management's intent to scale operations and reinforce Burlington's long term growth plans. Burlington Stores comes into this announcement with its shares at $306.62 and a 1 year return of 23.0%. Over 3 years the stock has returned 41.8%, and over 5 years 9.8%,...

Carvana (CVNA) is back in focus after its latest results showed quarterly and full year revenue and net income figures that were well above the prior year, alongside an updated long term growth plan. See our latest analysis for Carvana. Despite the strong earnings headlines, the share price has been volatile, with a 30 day share price return of 18.35% and a year to date share price decline of 16.35%. At the same time, the 1 year total shareholder return of 43.63% and very large 3 year total...

Asana has launched its AI-powered work management platform in the AWS Middle East (UAE) Region. The company is among the first enterprise collaborative solutions available on AWS Marketplace for this market. The rollout focuses on regulated and public sector customers that require data residency and enterprise-grade security controls. For investors following NYSE:ASAN, this move comes with the stock trading around $7.06 and showing pressure across multiple timeframes, including a 36.5%...

Salesforce (CRM) is back in focus after a busy quarter that combined a Q4 earnings beat, a new US$50b share repurchase authorization, a higher dividend, and fast growing AI driven Agentforce revenue. See our latest analysis for Salesforce. Even with the AI and buyback headlines, Salesforce’s recent share price performance has been weak. The 30-day share price return was 14.95%, and the year-to-date share price return was a 23.56% decline. The 1-year total shareholder return showed a 34.49%...

Apellis Pharmaceuticals (APLS) has drawn fresh attention after reporting fourth quarter and full year 2025 results, showing a move to full year profitability along with a weaker fourth quarter and a more cautious outlook for Syfovre. See our latest analysis for Apellis Pharmaceuticals. The recent earnings release and more cautious commentary around Syfovre seem to have weighed on sentiment, with a 7 day share price return of 6.01% decline and a year to date share price return of 19.03%...

Enviri (NVRI) is back on investors’ radars after recent trading left the shares around $18.93, with returns over the past month, past 3 months, and year showing mixed but meaningful moves. See our latest analysis for Enviri. Recent trading around $18.93 follows a 1 day share price return of 1.83%, while the 90 day share price return of 3.22% sits alongside a very large 1 year total shareholder return of 191.23%. This suggests that momentum has been building over a longer stretch rather than...

Ligand Pharmaceuticals (LGND) has reported FY 2025 results with fourth quarter revenue of US$59.7 million and basic EPS of US$2.27, while trailing twelve month figures show revenue of US$268.1 million and basic EPS of US$6.44. Over the past few quarters, the company has seen revenue move from US$42.8 million in Q4 2024 to US$45.3 million in Q1 2025, US$47.6 million in Q2 2025, US$115.5 million in Q3 2025 and US$59.7 million in Q4 2025, alongside basic EPS ranging from a loss of US$2.21 in Q1...

Unity Software (NYSE:U) is reviewing options for its China business, including a possible sale of its Chinese operations. The review focuses on how the company structures and potentially exits part or all of its presence in one of the largest digital markets. The outcome could influence how Unity allocates resources across regions and product lines in the future. For investors tracking NYSE:U, this review comes after a difficult period for the stock. Shares recently closed at $18.23, with a...

Recent analysis of Nutex Health’s hybrid model of micro-hospitals, hospital management services, and population health programs highlighted strong profitability metrics and claims of deep undervaluation, drawing fresh investor attention in the past week. An interesting angle is the company’s high free cash flow conversion, which some commentators argue could support a meaningful reassessment of its valuation if operating performance holds. We’ll now examine how Nutex Health’s highlighted...

Centrus Energy has in recent months secured a US$900 million High-Assay Low-Enriched Uranium contract from the U.S. Department of Energy and committed hundreds of millions of dollars to expand its Oak Ridge and Piketon enrichment plants, reinforcing its role in a reshaped Western nuclear fuel supply chain. An important takeaway is that Centrus now sits at the center of a multi‑billion‑dollar backlog through 2040, reflecting how policy shifts away from Russian uranium have turned its unique...

Intel, ticker NasdaqGS:INTC, announced a multi year AI partnership with SambaNova, including an equity investment in the AI chip startup. The company is pairing this AI push with internal change, as Kevin O’Buckley, who led Intel Foundry Services, has departed. These moves highlight parallel efforts in AI compute and foundry operations as Intel pursues a broader transformation in chips and manufacturing. Intel shares last closed at $45.61, with the stock up 3.4% over the past week and 15.8%...

AbCellera Biologics Inc. has reported its full-year 2025 results, with revenue rising to US$75.13 million and net loss easing to US$146.41 million, while also filing a US$45.54 million shelf registration for 15,030,034 common shares tied to an employee share offering. Alongside these financials, AbCellera’s shift into a clinical-stage biotech with advancing programs ABCL635 and ABCL575 and a nearly completed manufacturing facility signals a business model increasingly centered on internal...

International Seaways (INSW) is back in focus after reporting record fourth quarter net income and pairing those results with its largest ever quarterly dividend, a combined US$2.15 per share. See our latest analysis for International Seaways. The latest earnings and dividend news has arrived after a strong run in the shares, with a 30 day share price return of 26.6% and a year to date gain of 60.74%. That move sits on top of a very large 1 year total shareholder return of 143.19% and a 5...

Morgan Stanley and UBS recently upgraded Ermenegildo Zegna Group, following Q4 2025 sales that came in ahead of earlier expectations and highlighted broad-based strength in the core Zegna brand. Analysts pointed to strong engagement from Western affluent consumers across generations as evidence that Zegna’s brand and product positioning are resonating across key demographics. We’ll now examine how this renewed analyst confidence, driven by stronger-than-expected Q4 sales, may influence...

Coursera stock snapshot and recent performance Coursera (COUR) closed at US$6.41, with the share price showing a small gain over the past month but a decline over the past 3 months and past year, including a negative 3 year total return. The company reports annual revenue of US$757.5m and a net loss of US$51.0m. Recent annual figures indicate positive revenue and net income growth, factors some investors watch when assessing an education technology platform. See our latest analysis for...

Accenture (NYSE:ACN) has entered a multi-year partnership with French AI research firm Mistral AI to co-develop and deliver enterprise-grade AI solutions. The collaboration aims to embed Mistral AI’s models into Accenture’s internal operations and client offerings. Accenture plans to roll out dedicated training programs and regionally tailored AI solutions as part of this partnership. Accenture is moving to deepen its AI capabilities at a time when its share price, at $207.79, reflects a...

Arlo Technologies (ARLO) closed out FY 2025 with Q4 revenue of US$141.3 million and basic EPS of US$0.05, alongside net income of US$5.8 million. The trailing 12 month line shows revenue of US$529.3 million and basic EPS of US$0.14 as the business moves further into consistent profitability. Over the past six quarters, the company has seen revenue range from US$119.1 million to US$141.3 million per quarter, with basic EPS shifting from a loss of US$0.05 in late 2024 to positive contributions...

Shareholders of Exact Sciences, ticker NasdaqCM:EXAS, have approved the company’s acquisition by Abbott Laboratories. The vote clears a key hurdle for the transaction to proceed and marks a major corporate milestone. The deal is expected to reshape Exact Sciences’ role within the broader diagnostics and medical technology space. Exact Sciences focuses on diagnostics, including cancer related testing, which sits at the intersection of healthcare services and medical technology. The...

In February 2026, CCC Intelligent Solutions Holdings reported fourth-quarter 2025 revenue of US$277.87 million and net income of US$8.12 million, crossing US$1.06 billion in full‑year sales and issuing 2026 revenue guidance of US$1.15 billion to US$1.16 billion. The results highlighted nearly US$100 million in annual revenue from AI solutions, the EvolutionIQ acquisition to broaden insurance end‑markets, and a new US$500 million share repurchase authorization, including an accelerated US$300...

Helix Energy Solutions Group (HLX) is back in focus after reporting its highest fourth quarter revenue since 2013, positive free cash flow, and year end cash and liquidity that support recently secured multiyear contracts. See our latest analysis for Helix Energy Solutions Group. Those results come after a busy period, with Helix Energy Solutions Group reporting full year 2025 earnings, recording a US$18.06 million long lived asset impairment, completing its share repurchase program, and...

In February 2026, Arcutis Biotherapeutics reported fourth-quarter 2025 revenue of US$129.5 million and full-year revenue of US$376.07 million, moved to a Q4 net profit of US$17.4 million, and raised its 2026 net product revenue guidance to US$480 million–US$495 million while filing an omnibus shelf registration for multiple securities. The results highlight how rapid uptake of ZORYVE across expanded indications, including pediatric use, is beginning to translate into improving profitability...

Corporación América Airports (CAAP) caught investor attention after its January 2026 operating update, with total passenger traffic rising 8.8% year on year. Argentina and Brazil led with record and double digit gains. See our latest analysis for Corporación América Airports. That operating update lands after a mixed few weeks for the share price, with a 1 day share price decline of 1.59% and a 7 day share price decline of 2.56%, but a stronger 90 day share price return of 12.43% and a very...

If you are wondering whether Oddity Tech is now a bargain or a value trap, a closer look at how its current share price lines up with its fundamentals can help frame that question. The stock has seen large price swings recently, with a 7 day return of 63.2% decline, a 30 day return of 64.8% decline, and a year to date return of 70.2% decline, while the 1 year return sits at 75.3% decline from the current last close of US$11.77. These moves have prompted renewed attention on the business, as...

Founder Chip Wilson has escalated his activist campaign at lululemon athletica by pushing for a board overhaul and governance reforms. Wilson is seeking to add three independent directors, declassify the board, and has publicly criticized current governance and brand oversight. The campaign has moved into a full proxy fight, bringing boardroom tensions into the open for shareholders of NasdaqGS:LULU. lululemon athletica, traded as NasdaqGS:LULU, is coming into this governance fight after a...